TODENTJ-25-03-2019_TODENTJ-13-61
1553507725
Bentham Open
doi@benthamopen.net
Bentham Open
The Open Dentistry Journal
TODENTJ
1874-2106
02
28
2019
13
1
Manifestations in the Oral Mucosa of Erythromelalgia. A Case Report
Nansi
López-Valverde
Antonio
López-Valverde
Juan M
Ramírez
Rafael
Gómez de Diego
Introduction:
Erythromelalgia or erythermalgia, is a peripheral paroxysmal vascular disease of the distal extremities, although it can also affect the face, ears and knees. It is characterized by increased skin temperature, erythema and intermittent episodes of burning pain. Likewise, it can also be characterized by lesions of the oral mucosa.
Case report:
Here we present the case of a 6-year old female with EM presenting ulcerative and scaly lesions in the oral cavity and whitish linear branching ulcerative lesions on the tongue. Fabry disease and rheumatoid conditions were ruled out and there were no mutations in SCN9A gene. Treatment with voltage-gated sodium channel blockers (oxcarbacepine-Trileptal®) and anticonvulsants (Perampanel-Fycompa®) did not improve pain symptoms, however, performing moderate physical activity, use of comfortable footwear, and local application of cold resulted in the restoration of patient´s quality of life
Conclusion:
To our knowledge, this report described for the first time, the successful treatment of ulcerative lesions of the oral mucosa in Erythromelalgia. We believe that the treatments described here (exercise, comfortable footwear and local application of cold) could improve the quality of life of Erythromelalgia patients.
02
28
2019
61
66
TODENTJ-13-61
1
10.2174/crossmark_policy
opendentistryjournal.com
benthamopen.com
true
Peer Reviewed
Single blind
Checked with iThenticate
2018-11-20
2019-01-02
2019-01-24
2019-02-28
https://creativecommons.org/licenses/by/4.0/legalcode
10.2174/1874210601913010061
1553507725
https://opendentistryjournal.com/VOLUME/13/PAGE/61/
-
https://opendentistryjournal.com/contents/volumes/V13/TODENTJ-13-61/TODENTJ-13-61.pdf
-
https://opendentistryjournal.com/contents/volumes/V13/TODENTJ-13-61/TODENTJ-13-61.pdf
-
https://opendentistryjournal.com/contents/volumes/V13/TODENTJ-13-61/TODENTJ-13-61.pdf
-
https://opendentistryjournal.com/contents/volumes/V13/TODENTJ-13-61/TODENTJ-13-61.pdf
-
https://opendentistryjournal.com/contents/volumes/V13/TODENTJ-13-61/TODENTJ-13-61.pdf
-
https://opendentistryjournal.com/contents/volumes/V13/TODENTJ-13-61/TODENTJ-13-61.pdf
-
https://opendentistryjournal.com/contents/volumes/V13/TODENTJ-13-61/TODENTJ-13-61.pdf
-
https://opendentistryjournal.com/contents/volumes/V13/TODENTJ-13-61/TODENTJ-13-61.xml
Vasa
Klein-Weigel P.F.
47
91
2018
10.1024/0301-1526/a000675
Klein-Weigel PF, Volz TS, Richter JG.
Erythromelalgia.
Vasa
2018;
47
(2)
: 91-7.
Ann. Neurol.
Han C.
59
553
2006
10.1002/ana.20776
Han C, Rush AM, Dib-Hajj SD, et al.
Sporadic onset of erythermalgia: A gain-of-function mutation in Nav1.7.
Ann Neurol
2006;
59
(3)
: 553-8.
J. Am. Acad. Dermatol.
Cohen J.S.
43
841
2000
10.1067/mjd.2000.109301
Cohen JS.
Erythromelalgia: New theories and new therapies.
J Am Acad Dermatol
2000;
43
(5 Pt 1)
: 841-7.
An. Bras. Dermatol.
Leroux M.B.
93
86
2018
10.1590/abd1806-4841.20187535
Leroux MB.
Erythromelalgia: A cutaneous manifestation of neuropathy?
An Bras Dermatol
2018;
93
(1)
: 86-94.
Clin. Exp. Rheumatol.
Parker L.K.
35
80
2017
Parker LK, Ponte C, Howell KJ, Ong VH, Denton CP, Schreiber BE.
Clinical features and management of erythromelalgia: Long term follow-up of 46 cases.
Clin Exp Rheumatol
2017;
35
(1)
: 80-4.
Brain
Dib-Hajj S.D.
128
1847
2005
10.1093/brain/awh514
Dib-Hajj SD, Rush AM, Cummins TR, et al.
Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons.
Brain
2005;
128
(Pt 8)
: 1847-54.
J. Clin. Invest.
Drenth J.P.
117
3603
2007
10.1172/JCI33297
Drenth JP, Waxman SG.
Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders.
J Clin Invest
2007;
117
(12)
: 3603-9.
Arch. Dermatol.
Davis M.D.
139
1337
2003
10.1001/archderm.139.10.1337
Davis MD, Sandroni P, Rooke TW, Low PA.
Erythromelalgia: Vasculopathy, neuropathy, or both? A prospective study of vascular and neurophysiologic studies in erythromelalgia.
Arch Dermatol
2003;
139
(10)
: 1337-43.
Br. J. Dermatol.
Burns T.M.
153
174
2005
10.1111/j.1365-2133.2005.06441.x
Burns TM, Te Morsche RH, Jansen JB, Drenth JP.
Genetic heterogeneity and exclusion of a modifying locus at 2q in a family with autosomal dominant primary erythermalgia.
Br J Dermatol
2005;
153
(1)
: 174-7.
Arch. Dermatol.
Drenth J.P.
144
320
2008
10.1001/archderm.144.3.320
Drenth JP, Te Morsche RH, Mansour S, Mortimer PS.
Primary erythermalgia as a sodium channelopathy: Screening for SCN9A mutations: Exclusion of a causal role of SCN10A and SCN11A.
Arch Dermatol
2008;
144
(3)
: 320-4.
J. Med. Genet.
Yang Y.
41
171
2004
10.1136/jmg.2003.012153
Yang Y, Wang Y, Li S, et al.
Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia.
J Med Genet
2004;
41
(3)
: 171-4.
JAMA Neurol.
Geha P.
73
659
2016
10.1001/jamaneurol.2016.0389
Geha P, Yang Y, Estacion M, et al.
Pharmacotherapy for pain in a family with inherited erythromelalgia guided by genomic analysis and functional profiling.
JAMA Neurol
2016;
73
(6)
: 659-67.
Pain
Goldberg Y.P.
153
80
2012
10.1016/j.pain.2011.09.008
Goldberg YP, Price N, Namdari R, et al.
Treatment of Na(v)1.7-mediated pain in inherited erythromelalgia using a novel sodium channel blocker.
Pain
2012;
153
(1)
: 80-5.
Clin. Oral Investig.
Isola G.
2018
10.1007/s00784-018-2690-9
Isola G, Matarese M, Ramaglia L, Iorio-Siciliano V, Cordasco G, Matarese G.
Efficacy of a drug composed of herbal extracts on postoperative discomfort after surgical removal of impacted mandibular third molar: Arandomized, triple-blind, controlled clinical trial.
Clin Oral Investig
2018.
[Epub ahead of print].
J. Craniofac. Surg.
Cadavid A.M.H.
29
e614
2018
10.1097/SCS.0000000000004676
Cadavid AMH, de Campos WG, Aranha ACC, Lemos-Junior CA.
Efficacy of photocoagulation of vascular malformations in the oral mucosa using Nd: YAG Laser.
J Craniofac Surg
2018;
29
(6)
: e614-7.
Photomed. Laser Surg.
Matarese G.
35
702
2017
10.1089/pho.2017.4288
Matarese G, Ramaglia L, Cicciù M, Cordasco G, Isola G.
The effects of diode laser therapy as an adjunct to scaling and root planing in the treatment of aggressive periodontitis: A 1-year randomized controlled clinical trial.
Photomed Laser Surg
2017;
35
(12)
: 702-9.
Hum. Biol.
Demirjian A.
45
211
1973
Demirjian A, Goldstein H, Tanner JM.
A new system of dental age assessment.
Hum Biol
1973;
45
(2)
: 211-27.
ASDC J. Dent. Child.
Nolla C.M.
27
254
1960
Nolla CM.
The development of the permanent teeth.
ASDC J Dent Child
1960;
27
: 254-66.
Clin. Plast. Surg.
Ricketts R.M.
9
401
1982
Ricketts RM.
Divine proportion in facial esthetics.
Clin Plast Surg
1982;
9
(4)
: 401-22.
Joint Bone Spine
Lidove O.
83
421
2016
10.1016/j.jbspin.2015.11.001
Lidove O, Zeller V, Chicheportiche V, et al.
Musculoskeletal manifestations of Fabry disease: A retrospective study.
Joint Bone Spine
2016;
83
(4)
: 421-6.
Brain Res. Brain Res. Rev.
Dib-Hajj S.D.
60
65
2009
10.1016/j.brainresrev.2008.12.005
Dib-Hajj SD, Binshtok AM, Cummins TR, Jarvis MF, Samad T, Zimmermann K.
Voltage-gated sodium channels in pain states: Role in pathophysiology and targets for treatment.
Brain Res Brain Res Rev
2009;
60
(1)
: 65-83.
Pediatrics
Oaklander A.L.
131
e1091
2013
10.1542/peds.2012-2597
Oaklander AL, Klein MM.
Evidence of small-fiber polyneuropathy in unexplained, juvenile-onset, widespread pain syndromes.
Pediatrics
2013;
131
(4)
: e1091-100.
J. Vasc. Nurs.
Latessa V.
28
67
2010
10.1016/j.jvn.2009.11.002
Latessa V.
Erythromelalgia: A rare microvascular disease.
J Vasc Nurs
2010;
28
(2)
: 67-71.
Sandroni P, Davis MD, Harper CM, Rogers RS, Harper CM, O'Fallon WM.
Neruophysiologic and vascular studies in erythromelalgia: A retrospective analysis J Clin Neuromuscul
1999;
1
: 57-63.
J. Pain Res.
Low S.A.
10
973
2017
10.2147/JPR.S129661
Low SA, Robbins W, Tawfik VL.
Complex management of a patient with refractory primary erythromelalgia lacking a SCN9A mutation.
J Pain Res
2017;
10
: 973-7.
Undersea Hyperb. Med.
Fife C.E.
36
43
2009
Fife CE, Smart DR, Sheffield PJ, Hopf HW, Hawkins G, Clarke D.
Transcutaneous oximetry in clinical practice: Consensus statements from an expert panel based on evidence.
Undersea Hyperb Med
2009;
36
(1)
: 43-53.
Arch. Dermatol.
Davis M.D.
136
330
2000
10.1001/archderm.136.3.330
Davis MD, O’Fallon WM, Rogers RS III, Rooke TW.
Natural history of erythromelalgia: Presentation and outcome in 168 patients.
Arch Dermatol
2000;
136
(3)
: 330-6.
Acta Haematol.
Michiels J.J.
133
56
2015
10.1159/000360388
Michiels JJ, Berneman Z, Gadisseur A, Lam KH, De Raeve H, Schroyens W.
Aspirin-responsive, migraine-like transient cerebral and ocular ischemic attacks and erythromelalgia in JAK2-positive essential thrombocythemia and polycythemia vera.
Acta Haematol
2015;
133
(1)
: 56-63.
Clin. Exp. Dermatol.
Natkunarajah J.
34
e640
2009
10.1111/j.1365-2230.2009.03355.x
Natkunarajah J, Atherton D, Elmslie F, Mansour S, Mortimer P.
Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.
Clin Exp Dermatol
2009;
34
(8)
: e640-2.
J. Pain Res.
Keppel Hesselink J.M.
10
1
2016
10.2147/JPR.S122765
Keppel Hesselink JM, Kopsky DJ, Bhaskar AK.
Skin matters! The role of keratinocytes in nociception: A rational argument for the development of topical analgesics.
J Pain Res
2016;
10
: 1-8.
Arch. Dermatol.
Davis M.D.
138
17
2002
10.1001/archderm.138.1.17
Davis MD, Sandroni P.
Lidocaine patch for pain of erythromelalgia.
Arch Dermatol
2002;
138
(1)
: 17-9.
JAMA Dermatol.
Davis M.D.
151
1025
2015
10.1001/jamadermatol.2015.0511
Davis MD, Morr CS, Warndahl RA, Sandroni P.
Topically applied midodrine, 0.2%, an α1-Agonist, for the treatment of erythromelalgia.
JAMA Dermatol
2015;
151
(9)
: 1025-6.